CTSB and autoimmune disease: Genetic deletion of both cathepsins B and S in a mouse model of autoimmune encephalomyelitis attenuated the clinical phenotype and the progression of the disease, suggesting that inhibition by multiple cathepsins may be required to modulate autoimmune diseases, such as multiple sclerosis [48].